XML 79 R68.htm IDEA: XBRL DOCUMENT v3.22.2.2
Net Loss Per Share - Summary of Basic and Diluted Net Loss Per Share (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Numerator:        
Net loss $ (37,509) $ (53,373) $ (75,067) $ (49,329)
Net loss attributable to redeemable noncontrolling interests and noncontrolling interests (891) (4,912) (1,580) (1,556)
Net loss attributable to ATAI Life Sciences N.V. shareholders - basic (36,618) (48,461) (73,487) (47,773)
Net loss attributable to ATAI Life Sciences N.V. shareholders - diluted $ (36,618) $ (48,461) $ (73,487) $ (47,773)
Denominator:        
Weighted average common shares outstanding attributable to ATAI Life Sciences N.V. Stockholders - basic 153,971,202 132,265,075 153,751,456 125,797,732
Weighted average common shares outstanding attributable to ATAI Life Sciences N.V. stockholders - diluted 153,971,202 132,265,075 153,751,456 125,797,732
Net loss per share attributable to ATAI Life Sciences N.V. stockholders - basic $ (0.24) $ (0.37) $ (0.48) $ (0.38)
Net loss per share attributable to ATAI Life Sciences N.V. stockholders - diluted $ (0.24) $ (0.37) $ (0.48) $ (0.38)